Table 3 Impact of disease and treatment on patient day-to-day limitation
From: Patient-reported treatment burden of chronic immune thrombocytopenia therapies
Occupation or Job | Daily activities | Lifestyle | ||||
|---|---|---|---|---|---|---|
Group Mean (SD) | 2.11 | (1.35) | 2.25 | (1.24) | 2.45 | (1.25) |
Adjusted R 2 (N) | 0.17 | (512) | 0.17 | (512) | 0.18 | (512) |
Age | 0.03(.04) | 0.12(.04) | ** | 0.06(.04) | ||
AntiD aggregate bother interaction † | 0.20(.05) | **** | 0.16(.04) | *** | 0.14(.04) | ** |
CS aggregate bother interaction † | 0.12(.04) | ** | 0.11(.04) | * | 0.09(.04) | * |
IVIg aggregate bother interaction † | 0.21(.05) | **** | 0.15(.05) | ** | 0.17(.05) | ** |
Rituximab aggregate bother interaction † | 0.17(.05) | *** | 0.12(.05) | * | 0.12(.05) | * |
Splenectomy aggregate bother interaction † | 0.20(.05) | *** | 0.19(.05) | *** | 0.17(.05) | *** |
Frequency of dry bleeds (0 = No bleeds, 1 = bleeds) | 0.05(.05) | 0.13(.05) | ** | 0.15(.05) | ** | |
Time since last taking drug/procedure§ | 0.02(.04) | -0.04(.04) | -0.02(.04) | |||
Gender (0 = male; 1 = female) | -0.06(.04) | -0.06(.04) | -0.05(.04) | |||
Typical low platelet count (past year) | -0.12(.06) | * | -0.12(.06) | * | -0.11(.05) | * |
Number of ITP treatments (among 5 treatment types) | -0.17(.07) | ** | -0.12(.07) | -0.09(.04) | ||
Type of physician ‡ | -0.05(.04) | 0.04(.04) | 0.00(.05) | |||
Frequency of wet bleeds (0 = No bleeds, 1 = bleeds) | 0.13(.05) | ** | 0.13(.05) | ** | 0.17(.04) | *** |